Renal Cancer - Results from #2980

EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma. February 13, 2020

Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma. February 13, 2020

Predicting the ISUP grade of clear cell renal cell carcinoma with multiparametric MR and multiphase CT radiomics. February 12, 2020

Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC). February 12, 2020

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG). February 12, 2020

Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma. February 11, 2020

A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma. February 11, 2020

NK Cell-Based Immunotherapy in Renal Cell Carcinoma. February 11, 2020

EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma. February 10, 2020

Prognostic Significance of Preoperative Inflammatory Biomarkers and Traditional Clinical Parameters in Patients with Spinal Metastasis from Clear Cell Renal Cell Carcinoma: A Retrospective Study of 95 Patients in a Single Center. February 10, 2020

c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma. February 10, 2020

Nivolumab-Induced, Late-Onset, Steroid-Sensitive, High-Grade Pneumonitis and Durable Tumor Suppression in Metastatic Renal Cell Carcinoma: A Case Report. February 7, 2020

SEOM clinical guideline for treatment of kidney cancer (2019). February 7, 2020

Clinical and economic outcomes of treatment sequences for intermediate- to poor-risk advanced renal cell carcinoma. February 7, 2020

The effect of renal function change on renal cell carcinoma patients with tumor thrombus after nephrectomy and thrombectomy: a large Chinese center experience. February 6, 2020

Oncologic Outcomes in Young Adults With Kidney Cancer Treated During the Targeted Therapy Era. February 6, 2020

The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma. February 6, 2020

PD-L1 expression is an unfavourable prognostic indicator in Asian renal cell carcinomas. February 5, 2020

Replisome genes regulation by anti-tumor miR-101-5p in clear cell renal cell carcinoma. February 5, 2020

miR-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma. February 5, 2020

Page 150 of 456